KALA BIO
KALA
54 hedge funds and large institutions have $248M invested in KALA BIO in 2018 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 14 increasing their positions, 14 reducing their positions, and 15 closing their positions.
49% more call options, than puts
Call options by funds: $1.24M | Put options by funds: $833K
0% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 14
3.94% less ownership
Funds ownership: 77.38% → 73.43% (-3.9%)
16% less funds holding
Funds holding: 64 → 54 (-10)
18% less capital invested
Capital invested by funds: $300M → $248M (-$52.7M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
67% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$4.34M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$729K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$691K |
| 4 |
AA
ALPS Advisors
Denver,
Colorado
|
+$537K |
| 5 |
CM
Crestline Management
Fort Worth,
Texas
|
+$460K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$6.14M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$4.53M |
| 3 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
-$2.13M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$1.45M |
| 5 |
JP Morgan Chase
New York
|
-$1.3M |
KALA Hedge Fund Activity: Q2 2018 in Review
54 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q2 2018, worth a combined $248M — down 18% from $300M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of KALA and 5 opened new positions — a net loss of 10 holders — while 14 trimmed existing stakes and 14 added.
The largest buyer was Sofinnova Investments, adding an estimated $4.34M. The largest seller was Millennium Management, cutting an estimated $6.14M.
- 54 institutional investors held KALA BIO (KALA) as of Q2 2018, down from 64 in Q1 2018.
- Funds reported $248M of KALA BIO stock for Q2 2018, down 18% quarter-over-quarter.
- 5 funds opened new KALA BIO positions in Q2 2018 and 15 closed out, a net change of -10 holders.
- The largest KALA BIO buyer in Q2 2018 was Sofinnova Investments, an estimated $4.34M added.
- The largest KALA BIO seller in Q2 2018 was Millennium Management, an estimated $6.14M sold.
Based on aggregated 13F filings for Q2 2018.